Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer. Blaquier JB, Ortiz-Cuaran S, Ricciuti B, Mezquita L, et al. Clin Cancer Res 2023 Apr 24:CCR-22-1912. doi: 10.1158/1078-0432.CCR-22-1912.

Read + Share

Amedeo Smart

Independent Medical Education

Blaquier JB, Ortiz-Cuaran S, Ricciuti B, Mezquita L, et al. Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer. Clin Cancer Res 2023 Apr 24:CCR-22-1912. doi: 10.1158/1078-0432.CCR-22-1912.
PMID: 37093192